Efficacy and safety of QVA149 compared with salmeterol/fluticasone combination (SFC) in Chinese patients with moderate-to-severe COPD: A subgroup analysis from the LANTERN study

被引:0
|
作者
Zhong, Nanshan [1 ]
Wang, Changzheng [2 ]
Zhou, Xiangdong [3 ]
Zhang, Nuofu [1 ]
Patalano, Francesco [4 ]
Humphries, Michael [5 ]
Wang, Linda [5 ]
Banerji, Donald [6 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China
[2] Third Mil Med Univ, Xin Qiao Hosp, Inst Resp Dis, Chongqing, Peoples R China
[3] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China
[4] Novartis Pharma AG, Resp, Basel, Switzerland
[5] Beijing Novartis Pharma Co Ltd, Resp, Beijing, Peoples R China
[6] Novartis Pharmaceut, Resp, E Hanover, NJ USA
关键词
COPD; -; manag; ement; Bronchodilators; Treatments;
D O I
10.1183/13993003.congress-2015.PA990
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA990
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Cardiovascular Safety of QVA149 in Patients With Moderate-to-Severe COPD: Pooled Analysis of FLIGHT1 and FLIGHT2 Clinical Studies
    Fogel, Robert
    Ayers, Tim
    Banerji, Donald
    Maitra, Samopriyo
    Schubert-Tennigkeit, Agnes Annette
    CHEST, 2015, 148 (04)
  • [22] Efficacy and Safety of Indacaterol/Glycopyrronium (IND/GLY) Versus Salmeterol/Fluticasone in Chinese Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: The Chinese Cohort from the LANTERN Study
    Zhong, Nanshan
    Wang, Changzheng
    Zhou, Xiangdong
    Zhang, Nuofu
    Humphries, Michael
    Wang, Linda
    Patalano, Francesco
    Banerji, Donald
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (06) : 686 - 692
  • [23] Safety And Tolerability Of Qva149, Glycopyrronium And Tiotropium In Patients With Severe To Very Severe COPD: The Spark Study
    Decramer, M.
    Wedzicha, J. A.
    Sandstrom, T.
    Niewoehner, D.
    Taylor, A. Fowler
    D'Andrea, P.
    Arrasate, C.
    Berhane, I.
    Chen, H.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [24] Qva149 Demonstrates Superior Improvements In Health Status, As Measured By Sgrq, Compared With Placebo In Patients With Moderate-To-Severe COPD: The Flight2 Study
    Jones, P. W.
    Ayers, T.
    FowlerTaylor, A.
    Larbig, M.
    Thach, C.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [25] Qva149 Reduces Dyspnea In Patients With Moderate-To-Severe COPD As Measured By The Transition Dyspnea Index: The Flight2 Study
    Mahler, D. A.
    Ayers, T.
    FowlerTaylor, A.
    Larbig, M.
    Thach, C.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [26] Comparison of COPD Exacerbations With Once-Daily QVA149 Versus Twice-Daily Salmeterol/Fluticasone Combination: The ILLUMINATE Study
    Bateman, Eric
    Vogelmeier, Claus
    Chen, Hungta
    Banerji, Donald
    CHEST, 2014, 145 (03)
  • [27] COMPARISON OF COPD EXACERBATIONS WITH ONCE-DAILY QVA149 VERSUS TWICE-DAILY SALMETEROL/FLUTICASONE COMBINATION: THE ILLUMINATE STUDY
    Vogelmeier, C.
    Bateman, E. D.
    Chen, H.
    Banerji, D.
    THORAX, 2013, 68 : A184 - A185
  • [28] DUAL-BRONCHODILATION WITH ONCE-DAILY QVA149 IN PATIENTS WITH MODERATE-TO-SEVERE COPD: OVERVIEW OF THE IGNITE PROGRAM
    Price, D.
    Mezzi, K.
    Fedele, M. J.
    Chen, H.
    Banerji, D.
    THORAX, 2013, 68 : A183 - A184
  • [29] Once-daily QVA149 significantly improves lung function and symptoms compared to twice-daily fluticasone/salmeterol in COPD patients: The ILLUMINATE study
    Vogelmeier, Claus
    Bateman, Eric
    Pallante, John
    Bryant, Hannah
    Alagappan, Vijay
    D'Andrea, Peter
    He, Ellie
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [30] Once-daily QVA149 demonstrates superior improvements in patient-reported dyspnea compared to tiotropium in patients with moderate-to-severe COPD: The BLAZE study
    Mahler, Donald A.
    Decramer, Marc
    D'Urzo, Anthony
    Worth, Heinrich
    White, Tracy
    Alagappan, Vijay
    Chen, Hungta
    Kulich, Karoly
    Gallagher, Nicola
    Banerji, Donald
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42